Relationship Graph Explorer
Follow the connections
Every herb, ingredient, formula, gene target, and disease — connected through real research. Search, pick a subject, and navigate the graph in any direction.
🌿
Herb
6,826
→
⚗️
Ingredient
45,885
→
🧬
Gene Target
15,695
→
🏥
Disease
30,467
→
🧪
Evidence
23,295
trials · metas · refs
Plus 6,743 TCM formulas connecting herbs together
70 Diseases matching "thrombocytopenia"
Thrombocytopenia
Thrombocytopenia 4
Thrombocytopenia 3
Thrombocytopenia 5
Thrombocytopenia 6
Thrombocytopenia, Cyclic
Thrombocytopenia 1 (Disorder)
Thrombocytopenia 2 (Disorder)
Thrombocytopenia Robin Sequence
Thrombocytopenia Due To Sequestration
Thrombocytopenia-Absent Radius Syndrome
Thrombocytopenia, X-Linked, Intermittent
Thrombocytopenia, Anemia, And Myelofibrosis
Thrombocytopenia Due To Platelet Alloimmunization
Thrombocytopenia, X-Linked, With Dyserythropoietic
Thrombocytopenia, X-Linked, Without Dyserythropoie
Thrombocytopenia, X-Linked, With Or Without Dysery
Thrombocytopenia, Platelet Dysfunction, Hemolysis,
Sitosterolemia
Vater Association
Holt-Oram Syndrome
Sebastian Syndrome
May-Hegglin Anomaly
Sirenomelia Syndrome
Mild Thrombocytopenia
Macrothrombocytopenia
Nail-Patella Syndrome
Chronic Thrombocytopenia
Acquired Thrombocytopenia
Rubinstein-Taybi Syndrome
Isolated Thrombocytopenia
Kasabach-Merritt Syndrome
Essential Thrombocytopenia
Refractory Thrombocytopenia
Autoimmune Thrombocytopenia
Congenital Thrombocytopenia
Epstein Syndrome (Disorder)
Alloimmune Thrombocytopenia
Idiopathic Thrombocytopenia
Fechtner Syndrome (Disorder)
Intermittent Thrombocytopenia
Other Primary Thrombocytopenia
Immune Thrombocytopenic Purpura
Klippel-Trenaunay-Weber Syndrome
Amegakaryocytic Thrombocytopenia
Heparin-Induced Thrombocytopenia
Paris-Trousseau Thrombocytopenia
Idiopathic Thrombocytopenia (Itp)
Drug-Induced Immune Thrombocytopenia
Neonatal Alloimmune Thrombocytopenia
Neonatal Thrombocytopenia (Disorder)
Jacobsen Distal 11Q Deletion Syndrome
Autosomal Dominant Macrothrombocytopenia
Heparin-Induced Thrombocytopenia Type Ii
Acquired Amegakaryocytic Thrombocytopenia
Deafness, Autosomal Dominant 1 (Disorder)
Severe Fever With Thrombocytopenia Syndrome
Thrombasthenia-Thrombocytopenia, Hereditary
Congenital Amegakaryocytic Thrombocytopenia
Neonatal Alloimmune Thrombocytopenia (Nait)
Giant Platelet Syndrome With Thrombocytopenia
Dyserythropoietic Anemia With Thrombocytopenia
Heparin-Induced Thrombocytopenia With Thrombosis
Congenital Malformation Syndromes Involving Limbs
Macrothrombocytopenia-Stomatocytosis, Mediterranea
Macrothrombocytopenia, Autosomal Dominant, Tubb1-R
Radioulnar Synostosis With Amegakaryocytic Thrombo
Macrothrombocytopenia And Progressive Sensorineura
Radioulnar Synostosis With Amegakaryocytic Thrombo
Radioulnar Synostosis With Amegakaryocytic Thrombo
🏥 Disease / Health Topic
Thrombocytopenia
4
Clinical Trials
14
Meta-Analyses
0
PubMed References
📋 Sample Trials
NCT05360134
Platelet Augmentation Using C. Papaya Leaf Extract in Live Donor Liver Transplantation
Unknown
NCT03998982
Glycyrrhetinic Acid Combined With Dexamethasone in Management of Newly Diagnosed ITP
Unknown · Phase 4
NCT02556814
Caffeic Acid Combining High-dose Dexamethasone in Management of ITP
Completed · Phase 4
📊 Sample Meta-Analyses
CRD42013006288
Immunological testing for the diagnosis of heparin-induced thrombocytopenia: impact of optical density cut-off on sensitivity and specificity
Heparin induced thrombocytopenia (HIT).
CRD42020140054
Therapeutic Plasma Exchange (TPE) or Intravenous Immune Globulin (IVIG) in the Treatment of Heparin Induced Thrombocytopenia (HIT): a systematic review
Heparin Induced Thrombocytopenia (HIT) is an immune mediated prothrombotic disor
CRD42020146770
Systematic reviews and meta-analyses on the treatment and management of heparin-induced thrombocytopenia: a review of reviews
Approximately 12 million hospitalized patients each year are exposed to heparin
📚 Sample References
None linked yet.
🏥 All Disease / Health Topic data fields for Thrombocytopenia
🏥 Names
Disease Name
Thrombocytopenia
Alias Names
Thrombocytopenia, Unspecified; Thrombocytopenia
Topic Type
phenotype
🧬 Ontology Classifications
DisGeNET Type
phenotype
UMLS Type
Disease or Syndrome
MeSH Class
Hemic and Lymphatic Diseases
HPO Class
Abnormality of blood and blood-forming tissues
DO Class
disease of anatomical entity
🔗 External References
🔍 Raw view — every non-empty column on this row (30 fields)
name
Thrombocytopenia
alias name
Thrombocytopenia, Unspecified; Thrombocytopenia
topic type
phenotype
disgenet disease type
phenotype
umls disease type
Disease or Syndrome
mesh disease class
Hemic and Lymphatic Diseases
hpo disease class
Abnormality of blood and blood-forming tissues
do disease class
disease of anatomical entity
umls disease type id
T047
mesh disease class id
C15
hpo disease class id
HP:0001871
do disease class id
DOID:7
herb disease id
HBDIS002936
disgenet id
C0040034
mesh id
D013921
hpo id
HP:0001873
do id
1588
icd10 id
D69.6
🌿 Related Herbs
1 · contains this compound⚗️ Related Ingredients
2 · compounds in this herb📋 Clinical Trials
4 · subject of clinical studyNCT05360134 Platelet Augmentation Using C. Papaya Leaf Extract in Live Donor Liver Transplan
→ Thrombocytopenia
NCT03998982 Glycyrrhetinic Acid Combined With Dexamethasone in Management of Newly Diagnosed
→ Immune Thrombocytopenia
NCT02556814 Caffeic Acid Combining High-dose Dexamethasone in Management of ITP
→ Immune Thrombocytopenia
NCT02351622 Caffeic Acid Tablets as a Second-line Therapy for ITP
→ Immune Thrombocytopenia
📊 Meta-Analyses
12 · systematic reviewCRD42013006288 Immunological testing for the diagnosis of heparin-induced thrombocytopenia: imp
→ Heparin induced thrombocytopenia (HIT).
CRD42020140054 Therapeutic Plasma Exchange (TPE) or Intravenous Immune Globulin (IVIG) in the T
→ Heparin Induced Thrombocytopenia (HIT) is an immun
CRD42020146770 Systematic reviews and meta-analyses on the treatment and management of heparin-
→ Approximately 12 million hospitalized patients eac
CRD42020188701 Anticoagulant management of pediatric heparin-induced thrombocytopenia during ca
→ Heparin-induced thrombocytopenia is a rare thrombo
CRD42021240788 Characteristics, outcomes and incidence of heparin-induced thrombocytopenia (HIT
→ Incidence of heparin-induced thrombocytopenia in p
CRD42021249652 Cerebral venous thrombosis in patients with heparin-induced thrombocytopenia - a
→ Cerebral venous thrombosis in patients with hepari
CRD42021259546 Incidence of heparin-induced thrombocytopenia in patients with COVID-19: a meta-
→ COVID-19; heparin-induced thrombocytopenia
CRD42021269728 Utility of the 4T score and HEP score in diagnosing heparin induced thrombocytop
→ Heparin Induced Thrombocytopenia. An autoimmune re
CRD42018086389 Human exposure to mercury and its hematological effects: a systematic review
→ Mercury is a well known toxic substance that can p
CRD42023414120 Antithrombotic treatment of splanchnic venous thrombosis in myeloproliferative n
→ MPN is a group of heterogenous chronic hematologic
CRD42023414120 Antithrombotic treatment of splanchnic venous thrombosis in myeloproliferative n
→ MPN is a group of heterogenous chronic hematologic
CRD42023428671 Anticoagulant therapy in adult with COVID-19: a meta-analysis of randomized cont
→ COVID-19, triggered by SARS-CoV-2 Virus, dealt a g
How to read these connections
Each box lists records connected to the one you are viewing, and says how the connection was made. A connection shows that two records are related in the source data. It does not show that something works, is safe or should be used, and a record with many connections is not necessarily better studied or more effective.
- Study records (trials, systematic reviews, publications): the study names this subject. Registered or ongoing studies have no results here, and animal or cell research does not show an effect in people.
- Source-database links (for example herb and compound, compound and gene target): taken from the imported databases and not independently checked by us.
- Name matches (for example formula and herb, or a condition named in a study): found by matching names, so they can be wrong. Treat them as leads, not findings.